Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/5/2026
CMS Wins China Trial Approval for INHBE-Targeting Obesity siRNA Drug
3/4/2026
Sanofi Licenses Sino Biopharm's Transplant Therapy in $135M Upfront De...
3/4/2026
Minwei Biotech's siRNA Therapy MWX401 Cleared for Clinical Trials in C...
3/4/2026
Immunofoco Raises ~CNY 200M in Pre-IPO Round Ahead of Hong Kong Listin...
3/4/2026
Leman Biotech Raises ~CNY 200M to Advance Metabolism-Enhanced CAR-T Pl...
3/4/2026
CDE Invites Feedback on Draft Technical Guideline for Preventive mRNA ...
3/4/2026
China Biotech Outlicensing Surges Past US$52 Billion in Early 2026
3/3/2026
Prolium Launches with $50M to Advance China-Licensed T-Cell Engager in...
3/3/2026
Clickmab Biotech Secures Seed+ Funding to Boost AI Antibody Design Pla...
3/3/2026
LongBio Pharma's LP‑003 Shows Superior Efficacy Over Xolair in Phase ...
3/2/2026
WuXi XDC Partners With Earendil Labs on Next-Generation ADC Platform
3/2/2026
Sanofi Secures Two New China Approvals for Dupilumab
3/2/2026
NMPA Grants Conditional Approval to Sosimerasib for KRAS G12C-Mutant N...
3/2/2026
MediLink Advances HER3 ADC YL202 Into Two Phase III Trials in China
3/2/2026
RemeGen NDA for RC288 Dual-Target ADC Accepted by NMPA
3/2/2026
2026 Biotech Playbook: Hong Kong at the Centre of China’s Globalisati...
2/28/2026
bioMérieux CEO Flags "Negative Healthcare Market Evolution" in China
2/28/2026
Recent Executive Moves
2/27/2026
Evopoint Biosciences Highlights Igermetostat Data at ASCO GU 2026 in m...
2/26/2026
China Accelerates Dementia Research to Challenge U.S. Leadership
2/26/2026
Pfizer Updates Pneumococcal Vaccine Trial in China, Implications for I...
2/26/2026
Jiuyuan Files for Approval of Wegovy Biosimilar in China
2/26/2026
China Pharmaceutical Market Projected to Reach US$573B by 2033
2/26/2026
U.S. ITC to Probe China's Trade Status and Biotech Practices
2/26/2026
China Expands Mutual Recognition of Medical Tests to Streamline Care a...
2/26/2026
China's Biopharma Boom Attracts Global Investment Amid Innovation Surg...
2/26/2026
BMS-Partnered Bispecific ADC Achieves Dual Survival Milestones in Chin...
2/26/2026
China's Healthcare Reform Playbook: Boosting Births and Opening the Do...
2/25/2026
Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
2/25/2026
Henlius Expands Global Footprint with Exclusive Abbott Licensing Deal ...
Page:
1
/
381
Total number of articles:
11416
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit